UA94465C2 - Комбинированные препараты с содержанием бифепрунокса и l-dopa - Google Patents
Комбинированные препараты с содержанием бифепрунокса и l-dopaInfo
- Publication number
- UA94465C2 UA94465C2 UAA200900252A UAA200900252A UA94465C2 UA 94465 C2 UA94465 C2 UA 94465C2 UA A200900252 A UAA200900252 A UA A200900252A UA A200900252 A UAA200900252 A UA A200900252A UA 94465 C2 UA94465 C2 UA 94465C2
- Authority
- UA
- Ukraine
- Prior art keywords
- dopa
- bifeprunox
- combination preparations
- bifeprnnox
- simultaneous
- Prior art date
Links
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title abstract 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- CYGODHVAJQTCBG-UHFFFAOYSA-N Bifeprunox Chemical compound C=12OC(=O)NC2=CC=CC=1N(CC1)CCN1CC(C=1)=CC=CC=1C1=CC=CC=C1 CYGODHVAJQTCBG-UHFFFAOYSA-N 0.000 title 1
- 229950009087 bifeprunox Drugs 0.000 title 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000005793 Restless legs syndrome Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000010249 dopaminergic function Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение касается применения комбинированного препарата бифепрунокса или его N-оксида или фармакологически приемлемых солей указанных соединений и L-DOPA для одновременного, раздельного или последовательного применения при лечении расстройств, которые требуют восстановления допаминэргийной функции, в частности, болезни Паркинсона и синдрома неспокойных ног.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06115587 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94465C2 true UA94465C2 (ru) | 2011-05-10 |
Family
ID=37156018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200900252A UA94465C2 (ru) | 2006-06-16 | 2007-06-15 | Комбинированные препараты с содержанием бифепрунокса и l-dopa |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101478990A (ru) |
| AR (1) | AR061357A1 (ru) |
| BR (1) | BRPI0713691A2 (ru) |
| MX (1) | MX2008016226A (ru) |
| SA (1) | SA07280316B1 (ru) |
| TW (1) | TW200815031A (ru) |
| UA (1) | UA94465C2 (ru) |
-
2007
- 2007-06-13 SA SA7280316A patent/SA07280316B1/ar unknown
- 2007-06-13 TW TW096121306A patent/TW200815031A/zh unknown
- 2007-06-13 AR ARP070102582A patent/AR061357A1/es not_active Application Discontinuation
- 2007-06-15 CN CNA2007800225408A patent/CN101478990A/zh active Pending
- 2007-06-15 BR BRPI0713691-9A patent/BRPI0713691A2/pt not_active IP Right Cessation
- 2007-06-15 MX MX2008016226A patent/MX2008016226A/es not_active Application Discontinuation
- 2007-06-15 UA UAA200900252A patent/UA94465C2/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200815031A (en) | 2008-04-01 |
| AR061357A1 (es) | 2008-08-20 |
| SA07280316B1 (ar) | 2010-10-19 |
| MX2008016226A (es) | 2009-01-19 |
| CN101478990A (zh) | 2009-07-08 |
| BRPI0713691A2 (pt) | 2012-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| LU93321I2 (fr) | Ibrutinib, ou un sel pharmaceutiquement acceptable de celui-ci | |
| SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
| MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
| WO2006095029A3 (en) | Di-polymer protein conjugates and processes for their preparation | |
| WO2005097135A3 (en) | Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives | |
| UA102517C2 (ru) | Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы | |
| ZA200802897B (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of Alzheimer's Disease | |
| BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
| MY146429A (en) | 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e-]-[1,2,4]-triazolo-[1,5-c-]-pyrimidin-5-amine | |
| TW200637544A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| MX2009004561A (es) | Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor. | |
| ES2267706T3 (es) | Agentes como la nicotinamida o cardr para el tratamiento de trastornos de la piel. | |
| MX2010006204A (es) | Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| MX2009011869A (es) | Aislados antimicrobianos y anti-inflamatorios de extracto de regaliz. | |
| WO2007144422A3 (en) | Combination preparations comprising bifeprunox and l-dopa | |
| TW200612922A (en) | Inhibitors of hsp90 | |
| WO2009068708A3 (es) | Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo | |
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| WO2007144699A3 (en) | Process for the preparation of alfuzosin | |
| UA94461C2 (ru) | Водный экстракт листьев табака и его применение для лечения состояния зависимости | |
| ES2325291A1 (es) | "uso de un extracto de silybum marianum" | |
| MY148457A (en) | Combination preparations comprising slv308 and a dopamine agonist | |
| UA94465C2 (ru) | Комбинированные препараты с содержанием бифепрунокса и l-dopa |